For the 3D cell culture market to fully mature and realize its potential in clinical diagnostics and drug approval processes, the industry must overcome the hurdle of standardization and secure formal regulatory acceptance. Currently, protocols for generating complex models like organoids can vary significantly between laboratories, leading to issues with reproducibility—a critical...